BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6174463)

  • 1. Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro.
    Veselý J
    Int J Cancer; 1982 Jan; 29(1):81-5. PubMed ID: 6174463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells.
    Lemaire M; Momparler LF; Farinha NJ; Bernstein M; Momparler RL
    Leuk Lymphoma; 2004 Jan; 45(1):147-54. PubMed ID: 15061212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
    Momparler RL; Momparler LF; Samson J
    Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
    Veselý J; Pískala A
    Cancer Res; 1984 Nov; 44(11):5165-8. PubMed ID: 6207913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
    Momparler RL; Momparler LF; Samson J
    Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
    Raynal NJ; Charbonneau M; Momparler LF; Momparler RL
    Oncol Res; 2008; 17(5):223-30. PubMed ID: 18980019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
    Bouffard DY; Momparler LF; Momparler RL
    Anticancer Drugs; 1994 Apr; 5(2):223-8. PubMed ID: 7519483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Chabot GG; Momparler RL
    Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological concepts and the combination of cyclophosphamide with 5-aza-2'-deoxycytidine on L1210 in vivo.
    Zaharko DS
    J Immunopharmacol; 1985; 7(2):195-202. PubMed ID: 2411821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL; Momparler LF
    Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S; Rauscher F; Jakubowski A; Cadman E
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
    Momparler RL; Goodman J
    Cancer Res; 1977 Jun; 37(6):1636-9. PubMed ID: 66984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J; Cihák A
    Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells.
    Doré BT; Momparler RL
    Anticancer Drugs; 1992 Jun; 3(3):281-7. PubMed ID: 1381972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileukemic activity of streptozotocin (NSC-85998) and its analogs.
    Bhuyan BK; Fraser TJ; Buskirk HH; Neil GL
    Cancer Chemother Rep; 1972 Dec; 56(6):709-20. PubMed ID: 4267348
    [No Abstract]   [Full Text] [Related]  

  • 17. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
    Raynal NJ; Momparler LF; Rivard GE; Momparler RL
    Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
    Fodstad O; Pihl A
    Cancer Res; 1982 Jun; 42(6):2152-8. PubMed ID: 7200398
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-AZA-2'-deoxycytidine synergistic action with thymidine on leukemic cells and interaction of 5-AZA-dCMP with dCMP deaminase.
    Momparler RL; Rossi M; Bouchard J; Bartolucci S; Momparler LF; Raia CA; Nucci R; Vaccaro C; Sepe S
    Adv Exp Med Biol; 1986; 195 Pt B():157-63. PubMed ID: 2429505
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
    Momparier RL; Gonzales FA
    Cancer Res; 1978 Sep; 38(9):2673-8. PubMed ID: 79443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.